CC
MRTX

Callan Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Callan Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,431
Closed -$378K – 304
2023
Q4 		$378K Buy
6,431
+1,000
+18% +$58.8K 0.04% 149
2023
Q3 		$237K Buy
+5,431
New +$237K 0.03% 178